Taken together, altered insulin-antagonistic responses, including the cortisol axis, glucagon and ANS, in obese insulin-resistant individuals may contribute to the development of long-term dysglycaemia and, hypothetically, also type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.